FRANKLIN LAKES, N.J., Oct. 30, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched the new BD® Intraosseous Vascular ...

The BD® IO System is the only IO device on the market that can be placed after the extension set is attached ... "This important innovation represents a significant advancement in rapid ...

The BD® IO ... access to the circulatory system for adult and pediatric patients and is built for rapid intervention in varied emergent care environments. The BD® IO System is the only IO device ...

Difficulties in securing vascular access can significantly impede ... a clear demand for more accessible and user-friendly IO access devices, with a majority of clinicians recalling instances ...

The BD® IO System is the only IO device on the market that can be ... represents a significant advancement in rapid vascular access and builds on our ongoing commitment to support medical teams ...

The BD IO system is likely to enable access to rapid ... The intraosseous infusion devices allow for the administered fluids ...

FRANKLIN LAKES, N.J. - BD (Becton, Dickinson and Company) (NYSE: BDX), a prominent global medical technology firm, announced the release of its BD® Intraosseous Vascular Access System. This medical ...